REQUEST A DEMO
Total
USD $0.00
Search more companies

Mygenome Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology) | Medical Laboratories
Full name: Mygenome Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mygenome Sdn. Bhd is a biotechnology company specializing in Precision Medicine. The company offers molecular genomic tests using advanced techniques such as Next Generation Sequencing, Digital Gene Platform, Real-Time & Standard PCR. Their services include medical testing and genetic profiling for various conditions, as well as microbial product testing. Mygenome aims to provide affordable preventive genomic screening for early detection and is supported by a team of experienced scientists and researchers.

Headquarters
Suite G-03 & G-04, Ground Floor, Menara See Hoy Chan, No 374, Jalan Tun Razak
Kuala Lumpur; Federal Territories; Postal Code: 50400

Contact Details: Purchase the Mygenome Sdn. Bhd. report to view the information.

Website: http://mygenome.asia/

Basic Information
Outstanding Shares:
Purchase the Mygenome Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Mygenome Sdn. Bhd. report to view the information.
Incorporation Date:
November 27, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Mygenome Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-28.36%
Total operating revenue
-28.36%
Operating profit (EBIT)
9.58%
Net Profit (Loss) for the Period
9.58%
Total assets
-12.12%
Total equity
-56.11%
Operating Profit Margin (ROS)
-4.88%
Net Profit Margin
-4.88%
Return on Equity (ROE)
-65.77%
Debt to Equity Ratio
5.22%
Quick Ratio
-0.07%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?